Diagnosis · Implications · Management
ACOG · SMFM · Evidence-Based
▸ Rising cesarean rates worldwide are driving a parallel increase in CSP incidence.
Without timely intervention, CSP frequently leads to catastrophic complications including spontaneous uterine rupture and maternal death.
Urgent evaluation is mandatory upon diagnosis. Expectant management is generally contraindicated.
| Type | Invasion Depth |
|---|---|
| Accreta | Superficial myometrium |
| Increta | Deep myometrium |
| Percreta | Through serosa / bladder |
Early first-trimester TVUS is the primary and most sensitive modality for CSP diagnosis
| Type | Growth Trajectory | Prognosis & Risk | Risk Level |
|---|---|---|---|
| Type 1 Endogenic |
Grows endogenously toward the uterine cavity | May rarely progress toward viability; exceptionally high risk of Placenta Accreta Spectrum | HIGH |
| Type 2 Exogenic |
Grows exophytically toward bladder and uterine serosa | Ominous prognosis; imminent risk of spontaneous uterine rupture and life-threatening hemorrhage | CRITICAL |
Accurate classification is mandatory — it directly informs prognosis and surgical strategy.
These factors are independent predictors of severe intraoperative hemorrhage during surgical management.
| Approach | Procedure | Indication |
|---|---|---|
| Minimally Invasive | Hysteroscopic evacuation; ultrasound-guided sac aspiration | Stable, early CSP; fertility preservation desired |
| Surgical | Laparoscopic scar resection; uterine curettage; primary hysterotomy | Larger sacs; Type 2 CSP; failed medical management |
| Emergency | Emergency hysterectomy | Uterine rupture; uncontrollable hemorrhage |
| Adjunctive | Uterine Artery Embolization (UAE) | Pre-surgical hemorrhage prophylaxis; emergent hemorrhage control; fertility preservation |
Management must be individualized based on gestational age, structural type, hemodynamic stability, and fertility goals.